MedTrace Logo

Standard Care With or Without Early Palliative Care Provided by Palliative Care Specialist in Advanced Non-small Cell Lung Cancer Patients

NCT06786468 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 104

Last updated 2025-01-22

No results posted yet for this study

Summary

Early palliative care has been shown to improve the survival of advanced lung cancer patients. However, most of the clinical studies were performed in the era when systemic treatment options for this disease were limited. Currently, many effective treatment options are available, including targeted therapy and immunotherapy. These novel agents improve the treatment outcomes while having less toxicity compared to conventional chemotherapy. Moreover, medical oncologists are now trained to provide palliative care for patients. This study was designed to demonstrate whether early palliative care provided by the palliative care specialist still improves the quality of life or survival of advanced lung cancer patients compared to standard care provided by the medical oncologist.

Conditions

  • Lung Cancer - Non Small Cell
  • Lung Cancer (NSCLC)

Interventions

OTHER

Early palliative care integration

The patients will attend palliative care clinic once a month during the first three months together with routine oncology clinic visits

DRUG

Standard systemic treatment for advanced lung cancer

Standard systemic treatment for advanced lung cancer

Sponsors & Collaborators

  • Mahidol University

    lead OTHER

Principal Investigators

  • Lucksamon Thamlikitkul, MD, PhD · Mahidol University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-02
Primary Completion
2026-04-30
Completion
2027-04-30

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06786468 on ClinicalTrials.gov